Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biological Preservatives and Functional Ingredients	524.74M	489.31M			274.45M	217.46M	-
Biological Preservatives and Functional Ingredients Growth	7.24%	-			26.20%	-	-
Vitamins	224.21M	244.71M			411.15M	604.71M	-
Vitamins Growth	-8.38%	-			-32.01%	-	-
External Steam Sales	20.18M	37.19M			-	-	-
External Steam Sales Growth	-45.73%	-			-	-	-
Others	71.53M	55.40M			104.14M	45.14M	14.89M
Others Growth	29.13%	-			130.71%	203.21%	105.48%
Sales Materials	3.87M	787.36K			-	-	-
Sales Materials Growth	391.38%	-			-	-	-
Biotin	-	-			-	-	254.57M
Biotin Growth	-	-			-	-	1.29%
Nisin	-	-			-	-	122.66M
Nisin Growth	-	-			-	-	8.25%
Folic acid	-	-			-	-	54.32M
Folic acid Growth	-	-			-	-	-7.05%
Natamycin	-	-			-	-	42.43M
Natamycin Growth	-	-			-	-	4.38%
Polylysine	-	-			-	-	28.65M
Polylysine Growth	-	-			-	-	34.13%
Total	844.54M	827.40M			789.73M	867.31M	517.51M
Total Growth	2.07%	-			-8.95%	67.59%	5.12%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	614.55M	-			434.36M	380.99M	235.66M
China Growth	-	-			14.01%	61.67%	12.70%
Overseas	226.12M	-			355.37M	486.33M	281.86M
Overseas Growth	-	-			-26.93%	72.54%	-0.49%
Total	840.67M	-			789.73M	867.31M	517.51M
Total Growth	-	-			-8.95%	67.59%	5.12%

Source: S&P Global Market Intelligence.